Navigation Links
Clinical study shows biological and clinical activity in relapsed leukemia patients
Date:6/4/2008

LUGANO, SWITZERLAND, June 4, 2008 Finbarr Cotter, M.D., Ph.D., Professor of the Institute of Cell and Molecular Science at Barts and The London School of Medicine, today presented in an oral session "Clinical Caspase Activation in CLL by GCS-100: a Phase 2 Study" at the 10th International Conference on Malignant Lymphoma (10-ICML). The promising interim results from this ongoing clinical trial indicate that single-agent GCS-100 induces apoptosis (programmed cell death) in patients' CLL cells, reduces leukocyte count in some patients and is generally well tolerated. GCS-100 targets galectin-3, a protein over-expressed in cancer cells that promotes their survival, proliferation and metastasis.

The ongoing Phase 2 single-arm study of GCS-100 given intravenously as a single agent to relapsed CLL patients is designed to evaluate the effects of GCS-100 on various markers of apoptosis and to assess clinical activity and safety. Patients enrolled have had between one and two prior therapy regimens, which included chlorambucil, fludarabine, cyclophosphamide, and rituximab in combination or as a single agent. Of the nine patients enrolled to-date, six are evaluable for biological marker activity and five are evaluable for clinical activity.

The primary objective of the study is to evaluate the effect of GCS-100 on biomarkers of apoptosis in patients' CLL cells. Caspases -8 and -9 were activated in the CLL cells from all six evaluable patients, as measured by western blot analysis. DNA fragmentation in patients' CLL cells also was observed, strengthening the evidence that GCS-100 induces apoptosis.

The secondary objective of the study is to evaluate the effect of GCS-100 on peripheral blood leukocyte counts, which are aberrantly elevated in CLL patients. Of the five evaluable patients, two had significant reductions in leukocyte counts compared with baseline levels, including one with a 76% reduction and another with a 42% reduction and
'/>"/>

Contact: Michelle Linn
linnmich@comcast.net
508-362-3087
Linnden Communications
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Portsmouth, NH (PRWEB) , ... ... ... an integrated, full-service public relations, marketing, and creative design firm, today announced ... a regional public relations and social media campaign, content strategy, and marketing ...
(Date:7/7/2015)... ... July 07, 2015 , ... Office Practicum announced today that ... Financial Officer, effective July 6th, 2015. Ellen joins Office Practicum with more than ... dollar, global chemical company to early and growth-stage technology companies. , Purdy ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... an official accrediting body as designated by the Centers for Medicare and Medicaid ... experience and to enhance compatibility with mobile devices. , The most effective websites ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada announced that ... of gluten-free claims for gluten free oats and foods that contain them as ingredients. ... Program (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, VP ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... patient advocate, will be recognized by the White House as a “Champion of ... newly-launched President’s Precision Medicine Initiative, the Champions of Change program recognizes Gleason and ...
Breaking Medicine News(10 mins):Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Office Practicum Announces new CFO 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3
... ATLANTA, Jan. 23 GREENGUARD Environmental,Institute ... quality, congratulates,the recipients for this year,s Ken ... Two proposals from prominent graduate,programs will receive ... to,the professional building community, ranging from the ...
... visitors to Gunther von Hagens, BODY WORLDS ... Day holiday weekend -- over 21,000 visitors in three days -- The ... museum hours and host a round-the-clock 40 ... Starting at 8:00 a.m. January 25th, The Tech will ...
... Support for Bipartisan Legislation, The Breast, Cancer Patient ... Landrieu (D-LA) and Representatives DeLauro (D-CT) and Moran (R-KS) -, ... Election Year, Campaign to Encourage Women to Speak ... 23 Today, at a Capitol Hill,press conference, actress Marcia ...
... that seem to influence outcome , , WEDNESDAY, Jan. 23 ... to the two common antidepressant drugs citalopram (brand name ... researchers. , The team at the Max Planck Institute ... the gene for a protective transporter protein called P-gp, ...
... , Insomnia occurs when people have trouble falling asleep ... While a brief case of insomnia can arise due to ... Americans report having a chronic form of insomnia that keeps ... the insomnia, which is a serious and often debilitating condition, ...
... for cardiac repair will be examined during the ... the European Society of Cardiology which starts today in ... engineered heart tissue (EHT) in Germany, indicate the great ... repair. Over one hundred top cardiologists from all over ...
Cached Medicine News:Health News:GREENGUARD 2008 Memorial Fellowship Winners Will Examine Design 2Health News:Museum Open Around the Clock - BODY WORLDS 2 and The Tech Host 40 Hour Marathon! 2Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 2Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 3Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 4Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 5Health News:Genetics May Determine Antidepressants' Effectiveness 2Health News:AASM statement on use of sleep medications 2Health News:AASM statement on use of sleep medications 3
(Date:7/7/2015)... BOSTON , July 7, 2015   ... the "Company"), a leader in embolic protection systems ... Embolic Protection System integrated with MicroNet ™ ... European Coronary Stent New Product Innovation Award.  Through ... team of analysts and consultants recognize the successful ...
(Date:7/7/2015)... , July 7, 2015 EnteroMedics Inc. (NASDAQ: ... that use neuroblocking technology to treat obesity, metabolic diseases, ... previously announced public offering of 32,000,000 units. Each unit consists ... A warrant to purchase one share of common stock ... whose purchase of units in the offering would result ...
(Date:7/7/2015)... July 7, 2015 Oasmia Pharmaceutical ... within human and veterinary oncology, has filed a registration ... Commission, in connection with the proposed public offering of ... The number of American Depositary Shares, representing ordinary shares, ... offering have not yet been determined. An Investor Roadshow ...
Breaking Medicine Technology:InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2
...  SuccessEHS announces the release of the new Patient-Centered ... with a dependable roadmap to NCQA 2011 PCMH ... meaningful use criteria. The release of the Toolkit ... support the patient-centered care model, and underscores SuccessEHS,s continued ...
...   USANA Health Sciences, Inc. (NYSE: USNA ... has hired Doug Braun as its new vice ... Macuga , USANA,s former vice president of marketing, public relations and ... http://photos.prnewswire.com/prnh/20110110/LA27593LOGO ) Doug Braun brings to ...
Cached Medicine Technology:SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 2SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 3SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 4New Management Changes Poise USANA for Further Growth 2New Management Changes Poise USANA for Further Growth 3
... instrument is the cycler that revolutionized thermal ... ensure consistent results, experiment-to-experiment and block-to-block. This ... cycler, it's a platform for new features ... Engine thermal cycler chassis, does not include ...
Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature...
... maximizes what a thermal cycler can do ... formats, an easy graphic interface, and best ... PCR. The iCycler thermal cycler will raise ... can do for you.,, iCycler Thermal Cycler ...
... Engine Tetrad™ thermal cycler expands the envelope ... Engine™ cyler. It has four times the ... size, providing very high throughput for laboratories ... as sequencing or diagnostic labs. Four ...
Medicine Products: